Zymeworks Inc.

ZYMENASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
29.31 USD
↗ 1.84 (6.68%)AT CLOSE (11:59 AM EDT)
29.49
↗ 0.18 (0.63%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
29.49
↗ 0.18 (0.63%)
🔴Market: CLOSED

ZYME is currently priced at $29.31. ZYME shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Strong Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 26, 2026.

Open?$27.56
High?$30.62
Low?$27.48
Prev. Close?$27.47
Volume?1.2M
Avg. Volume?579.9K
VWAP?$29.33
Rel. Volume?2.10x
Bid / Ask
Bid?$29.30 × 1.0K
Ask?$29.44 × 100
Spread?$0.14
Midpoint?$29.37
Valuation & Ratios
Market Cap?2.1B
Shares Out?71.0M
Float?44.0M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?26.08
EPS?-$2.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
264
Market Cap
2.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.zymeworks.com
Listed
2017-04-28
Address
108 PATRIOT DRIVE, SUITE A
MIDDLETOWN, DE 19709
Phone: 302-274-8744
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
1
Momentum?
3
Short Sent.?
49
Piotroski F-Score?1/9Weak
Altman Z-Score?-0.60Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.31%High
Short Interest?4.5M
Days to Cover?8.5
Free Float44.0M
Avg Daily Volume533.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?6.32Strong
Quick Ratio?6.32Strong
Cash Ratio?3.80Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
26.08HIGH▾
P/S?
Peers
100
S&P
3
56.45HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
51.62HIGH▾
Returns & Efficiency
ROE?
S&P
3
-186.6%WEAK▾
ROA?
S&P
3
-37.8%WEAK▾
Cash Flow & Enterprise
FCF?$-120544000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day
MarketsMoversWatchlist